Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Sold by Shaker Investments LLC OH

Shaker Investments LLC OH trimmed its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 92.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 755 shares of the company's stock after selling 9,008 shares during the quarter. Shaker Investments LLC OH's holdings in Medpace were worth $251,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. R Squared Ltd acquired a new position in Medpace during the fourth quarter worth $30,000. Stone House Investment Management LLC acquired a new position in shares of Medpace during the 3rd quarter valued at about $33,000. Ashton Thomas Securities LLC purchased a new stake in shares of Medpace in the third quarter valued at about $37,000. Capital Performance Advisors LLP acquired a new stake in Medpace during the third quarter worth about $46,000. Finally, True Wealth Design LLC raised its stake in Medpace by 16,800.0% during the third quarter. True Wealth Design LLC now owns 169 shares of the company's stock worth $56,000 after purchasing an additional 168 shares during the period. 77.98% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

MEDP has been the subject of several analyst reports. Baird R W cut shares of Medpace from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, October 23rd. William Blair reissued an "outperform" rating on shares of Medpace in a research note on Tuesday, October 22nd. TD Cowen decreased their price target on Medpace from $413.00 to $372.00 and set a "buy" rating on the stock in a research note on Wednesday, October 23rd. Finally, Robert W. Baird raised their price objective on Medpace from $354.00 to $362.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $381.44.

Medpace Price Performance

Shares of MEDP traded down $2.66 during mid-day trading on Friday, reaching $339.75. The company's stock had a trading volume of 180,347 shares, compared to its average volume of 266,855. Medpace Holdings, Inc. has a 12-month low of $302.01 and a 12-month high of $459.77. The stock has a market cap of $10.56 billion, a PE ratio of 29.75, a price-to-earnings-growth ratio of 1.85 and a beta of 1.36. The company's 50 day moving average is $343.70 and its 200 day moving average is $348.83.

Medpace (NASDAQ:MEDP - Get Free Report) last announced its quarterly earnings results on Monday, February 10th. The company reported $3.67 EPS for the quarter, beating the consensus estimate of $2.96 by $0.71. Medpace had a net margin of 17.66% and a return on equity of 50.87%. As a group, sell-side analysts anticipate that Medpace Holdings, Inc. will post 11.93 EPS for the current fiscal year.

Medpace Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.